Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells

H Schneck, Xiangyan Ruan, Harald Seeger, Michael A. Cahill, Tanja Fehm, Alfred O. Mueck, Hans Neubauer
In: Gynecological Endocrinology · 2012 · vol. 29(2) , pp. 160–162 · doi:10.3109/09513590.2012.730572 · PMID:23116217 · W2070138500
article OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-29 ⓘ

Dienogest and medroxyprogesterone acetate alone, and NET at all concentrations, increased proliferation in human breast cancer cells overexpressing PGRMC1, with dienogest also enhancing proliferation in combination with low estradiol.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVES: Dienogest (DNG) is already used in hormone therapy, since recently being also the progestogenic component of the first estradiol based contraceptive pill. Data on breast cancer risk are currently not available. Progesterone receptor membrane component 1 (PGRMC1) is highly expressed in tissues of breast cancer patients and has already been proposed as a predictor for breast cancer risk. METHODS: MCF-7 cells overexpressing PGRMC1 were stimulated with DNG, medroxyprogesterone acetate (MPA), norethisterone (NET) and progesterone (P) as well as sequentially and continuously combined with estradiol (E2). RESULTS: DNG and MPA alone elicited a significant proliferation at 10⁻⁶ and 10⁻⁵ M. NET increased cell proliferation at all concentrations tested whereas P showed no effect. E2 alone elicited a significant increase at 10⁻¹⁰ M, no effect was seen at 10⁻¹² M. Addition of the progestins (10⁻⁶ M) to E2 at 10⁻¹⁰ M had, compared to E2 only, no additional proliferating effect. However, at the low E2 concentration, DNG, MPA and NET significantly increased the E2-stimulated cell proliferation. CONCLUSION: DNG increased proliferation alone and in combination with low E2 concentrations. Thus a progestogen-derived breast cancer risk in the presence of low E2 concentrations cannot be excluded at least in women overexpressing PGRMC1.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

Cited by (3)

References (25)

Cited by (3)

Source provenance

openalex
last seen: 2026-05-11T04:52:51.374891+00:00
unpaywall
last seen: 2026-09-19T06:31:22.526400+00:00
License: CC0 · commercial use OK